Summary
Dmitry Soloviev is a radiochemist and leader with 11+ years in PET/SPECT radiopharmaceutical development, currently heading Radiochemistry at the University of Glasgow to support preclinical and clinical imaging studies. He has a deep track record across academia, industry and international consultancy—from setting up cyclotron centres for the IAEA to co-founding a diagnostics start-up—bridging hands-on GMP production, QC leadership and research translation. Dmitry’s PhD in fluororganic chemistry underpins decades of specialty work in radiotracer chemistry for neuroimaging and oncology, and he has repeatedly built operational radiochemistry capability at major PET centres. Based in Scotland, he combines scientific rigor with practical implementation, often advising on centre setup and regulatory-compliant radiopharmaceutical production—an unusual mix of bench expertise and systems-level delivery.
11 years of coding experience
18 years of employment as a software developer
Doctor of Philosophy (Ph.D.), Chemistry of fluororganic compounds, Doctor of Philosophy (Ph.D.), Chemistry of fluororganic compounds at Saint Petersburg State Institute of Technology (Technical University)
Master of Science (M.Sc.), Chemistry and technology of synthetic biologically active compounds, Master of Science (M.Sc.), Chemistry and technology of synthetic biologically active compounds at St Petersburg State Institute of Technology (Technical University), St Petersburg, Russian Federatio
Russian, Italian, French